What it sells
Artificial Intelligence for your medical billing team
Business model breakdown
Buyer: who owns the budget?
UnverifiedRevenue cycle / RCM leaders at provider organizations (inferred).
Trigger: what makes them buy now?
UnverifiedDenials, appeals and claim status follow-up are labor-intensive; claims go uncollected.
Workflow: what inputs become what output?
Agents check claim status, file appeals, resolve denials, post payments and handle eligibility across clearinghouse and payer portals for 3500+ payers; no eng/IT integration; first results in 48 hours.
Economics: what it saves and how it charges
Claims +3.5 pts EBITDA margin on a $100M-revenue practice, net collection rate +2.6 pts, about 22% lower cost to collect; NextGen: 75% lower cost on claim status.
Distribution: how it reaches customers
Demo-led (Watch a Demo / Talk to Us), case studies, podcast and payer lookup content.
Funding history and coverage
| Round date | Stage | Amount | Investors | Source |
|---|---|---|---|---|
| 2025-10-29 | — | $100M | — | news.google.com |
| 2025-10-29 | Y Combinator Summer 2024 | $100M | Y Combinator | ycombinator.com |
Profiles summarize public reporting and company websites. Business-model notes are MaxBC's reading of that material, not confirmed facts; unknowns are left blank rather than guessed. Updated 2026-10-12.